adzenys xr-odt
Generic: amphetamine
Labeler: neos therapeutics brands, llcDrug Facts
Product Profile
Brand Name
adzenys xr-odt
Generic Name
amphetamine
Labeler
neos therapeutics brands, llc
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
amphetamine 18.8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70165-030
Product ID
70165-030_3f92012c-7250-9c32-e063-6394a90adb47
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA204326
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2016-02-16
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70165030
Hyphenated Format
70165-030
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adzenys xr-odt (source: ndc)
Generic Name
amphetamine (source: ndc)
Application Number
NDA204326 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 18.8 mg/1
Packaging
- 30 BLISTER PACK in 1 CARTON (70165-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f92012c-7250-9c32-e063-6394a90adb47", "openfda": {"nui": ["N0000175739", "N0000175729"], "upc": ["0370165015301", "0370165010306", "0370165030304", "0370165005302", "0370165025300", "0370165020305"], "unii": ["CK833KGX7E"], "rxcui": ["1739803", "1739809", "1739813", "1739815", "1739819", "1739821", "1739825", "1739827", "1739831", "1739833", "1739837", "1739839"], "spl_set_id": ["c1179269-00b5-48ea-972d-31e614e99b7e"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "manufacturer_name": ["Neos Therapeutics Brands, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (70165-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "70165-030-30", "marketing_start_date": "20160216"}], "brand_name": "Adzenys XR-ODT", "product_id": "70165-030_3f92012c-7250-9c32-e063-6394a90adb47", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "70165-030", "dea_schedule": "CII", "generic_name": "Amphetamine", "labeler_name": "Neos Therapeutics Brands, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adzenys XR-ODT", "active_ingredients": [{"name": "AMPHETAMINE", "strength": "18.8 mg/1"}], "application_number": "NDA204326", "marketing_category": "NDA", "marketing_start_date": "20160216", "listing_expiration_date": "20261231"}